Journal: Frontiers in Pharmacology
Article Title: Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
doi: 10.3389/fphar.2021.588306
Figure Lengend Snippet: Dose-response curves showing respectively the effects of ssAPT, APTSAP, APTSAPKQ, pBlue_SAP and pBluescript II KS (+) on U87MG cells. Cells (1.6 × 10 3 /well) were seeded in 96-well plates in a final volume of 200 µl of medium (5% FBS) containing the appropriate concentrations (0, 0.001, 0.01, 1, 10, 50 μmol/L) of ssAPT or the appropriate concentrations (0, 0.001, 0.01, 0.02, 0.05 and 0.1 μmol/L) of APTSAP, APTSAPKQ, pBlue_SAP and pBluescript II KS (+) for 96 h. All the plasmids were denatured at 95°C for 2 min in 10 mM Tris/HCl buffer pH 7.5 containing 100 mM NaCl and 2.5 mM KCl immediately before use. Cell viability was examined using a MTS assay and expressed as percentage of control untreated cells. ssAPT IC 50 : 4.30 × 10 −6 ± 1.70 × 10 −6 M (mean ± S.E.M.); APTSAP IC 50 : 1.30 × 10 −8 ± 2.42×10 −9 M (mean ± S.E.M.). The data reported are representative of a set of at least three independent experiments and are reported as mean ± SD.
Article Snippet: APTSAP, APTSAPKQ and pBlue_SAP vectors DNA synthesis and codon optimization for mammalian cell expression were from GenScript (United States), while the single strands corresponding to AS1411 (ssAPT) was purchased from Eurofins Genomics (Germany).
Techniques: MTS Assay, Control